Carbon nanodots (CNDs), reported
as polyatomic carbon domains surrounded
by amorphous carbon frames, have drawn extensive attention due to
their easy-to-synthesis, outstanding electronic properties, and superior
biocompatibility. However, substantial assessments regarding their
biological performance are still needed, considering the complex nature
of this type of relatively new nanoparticles. In this report, CNDs
derived from urea and citric acid (U-CNDs) are investigated in the
treatment of two cell lines, EA.hy926 and A549 cells, to examine the
biocompatibility, cellular uptake, and antioxidation effect. The intracellular
uptake study suggests an energy-dependent transport process into the
cells mainly involving macropinocytosis and lipid raft-mediated endocytosis
pathways. Moreover, the U-CNDs mostly target the mitochondria and
present strong antioxidative effects by scavenging reactive oxygen
species (ROS) in cells. Overall the findings in this report manifest
that the U-CNDs could serve as a bioimaging reagent and antioxidant
causing little deleteriousness in the respects of viability, plasma
membrane integrity, and mitochondrial activity in both cell lines,
and demonstrate some efficacy for inhibiting the metabolic activities
of A549 cancer cells at higher concentration.